2023 annual financial data

Keros Therapeutics 2023 Net margin

Direct answer

Net margin was -101,319.21%.

Operating income was -169.94M USD and net income was -152.99M USD.
Operating cash flow was -124.51M USD.

Get free Keros Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
151,000 USD
Operating income
-169.94M USD
Net income
-152.99M USD
Operating cash flow
-124.51M USD